Matinas BioPharma (MTNB)

• Market cap: $4.1M
• 1 day: 8.47%
• 5 days: 1.2%
• 1 month: 4.88%
• 3 months: -14.78%
• 6 months: -68.93%
• Year to date: 3.23%
• 1 year: 18.3%
• 5 years: -98.85%
• 10 years: -99.67%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Employees: 34